Lakers waive Dalton Knecht, Bucks part ways with Kevin Porter Jr.: the preseason cut and the hidden bill

The 2026-27 preseason cutdown opened with two moves placed side by side on the wire: the Los Angeles Lakers waived Dalton Knecht, and the Milwaukee Bucks parted ways with Kevin Porter Jr. For a transaction analyst, the story sits in the timing and in how each team handled its payroll bill, not in the shock of the names. I went back through both teams' decision chains over the past 18 months, checked the cutdown calendar, guarantee dates and tax structure. The pattern is familiar: teams do not cut a player because of one game; they cut because a payment is about to come due. The Lakers half has a named source: ESPN's Shams Charania. The Bucks half, across the Porter material, carries no attributed source. I separate the two because their reliability differs. With Knecht, the information is enough to build a timeline. With Porter, every conclusion needs a verification tag. That is the rule: internal sources confirm, they do not replace data. When half the story has no source, the analyst writes slower, not louder. The operating context sits in two different calendars. The Lakers enter 2026-27 under roster and tax pressure. A guaranteed rookie-scale deal, even a small one, occupies a slot and creates opportunity cost. If the team wants room for a two-way wing, a backup center or a later trade slot, waiving Knecht is the cheapest way to regain control. For the Bucks, the issue is heavier: Porter is tied to right knee surgery in April 2026, and last season is described by a strong stat line attached to a 38-game sample. Those facts do not automatically cancel each other, but they demand cross-checking. Based on my experience watching games through cutdown periods, teams often announce a basketball reason while the payroll decides the date. A waived player can still train well and fit the scheme, but no longer fit the money. With Knecht, the issue is contract age and guarantee level. With Porter, the issue is medical risk and the guarantee trigger. Two teams, one calculation: keep the player who is cheaper in total cost, not the one with the bigger name. Porter's stat line needs the first cut: 17.4 points, 5.2 rebounds, 7.4 assists and 2.2 steals. That is a ball-handler's surface line, attached to a player described as a 38-game roster-trim casualty. Numbers do not lie — only sources know how to paint them. Three explanations are plausible. First, the line may be per-36 normalization, turning a bench role into starter numbers. Second, a 38-game sample is small enough for a few hot nights to lift the average. Third, the data may aggregate NBA and European competition, where pace and role differ. Until those three are separated, the line is a hypothesis, not a biography. I checked how teams have handled small samples before. A guard with 38 games, knee surgery and strong efficiency gets priced in two layers: ability and availability. Ability may justify a short deal from a team that needs creation. Availability pulls the price down, because the team pays for games missed. The Bucks, with a crowded payroll, cannot pay for a medical bet that also eats a rotation slot. Waiving Porter pushes the risk to the market, where another team can sign a non-guaranteed deal and test him. On the Lakers side, Knecht is the reverse problem. He does not carry Porter's medical risk, but he is caught between two waves: the team needs more defense and a softer payroll. A young player on a controllable deal is usually a trade asset. When the Lakers waive him, they accept losing some value to regain a slot. That signals another move: signing a free agent, taking a small contract in a trade, or simply holding space for a name that will appear after league-wide cuts. In the NBA, a waiver is not an ending; it is an open door. The biggest blind spot is the official story. Both teams will talk about opportunity, scheme and development. Those words are not false, but they are incomplete. A preseason waiver is often designed to avoid a guarantee date, open a two-way slot, or preserve room below a tax threshold. For Porter, the official story may be health. For Knecht, it may be rotation fit. Both can be true, but the financial motive sets the announcement date. Internal sources are most expensive — and cheapest — in the V.League as in the NBA: expensive when they must be verified, cheap when used to fill a data gap. I do not dismiss the rational part of these decisions. The Lakers can reasonably believe a flexible roster slot is worth more than a player outside the rotation plan. The Bucks can reasonably believe a guard coming off knee surgery cannot be a priority in a season that needs stability. That rational part deserves acknowledgment, because transaction analysis is not a verdict. But it does not answer the price question: who pays for the risk, who gains if the player recovers, and who absorbs the loss if the next contract breaks. With Knecht, the market will split immediately. Teams needing a cheap shooter will call. Teams needing salary matching will wait. His value depends on whether a new team needs off-ball movement. If yes, a short deal is a door. If not, he may slide through camp and become a fallback. With Porter, the market will be slower. Any team signing him must answer two questions: is the right knee ready, and does the contract protect the team? A non-guaranteed deal is a test. A protected deal is an option purchase. The money here is not only salary. It is the opportunity cost of a slot, the price of patience, the probability a young player develops in 12 months. I still start with the balance sheet: every cut needs a break-even point. The Lakers calculate it in roster slots. The Bucks calculate it in medical risk. Different break-evens, same action: move the player to the market before the bill closes. The story continues. Teams cut in waves, agents call, two-way slots open. The next 10 days will tell who was right. I do not look at the future; I read the past faster than others. The past says preseason waivers often open a short signing, a small trade, or a medical bet repriced. Do not ask who is coming; ask why they left. The answer usually sits on the guarantee date, not in the stat line.